Meihua International Medical Technologies Co Ltd (MHUA)
$0.84
Live
Performance
- $0.80$1.08$0.84
4.75%
Downside
Day's Volatility :25.57%
Upside
21.86%
- $0.60$2.81$0.84
28.45%
Downside
52 Weeks Volatility :78.61%
Upside
70.11%
Returns
| Period | Meihua International Medical Technologies Co Ltd | Index (Russel 2000) |
|---|---|---|
3 Months | 7.13% | 0.0% |
6 Months | 65.06% | 0.0% |
1 Year | -43.55% | 0.0% |
3 Years | -91.87% | -23.0% |
Highlights
Market Capitalization | 25.6M |
Book Value | $5.73 |
Earnings Per Share (EPS) | 0.37 |
PE Ratio | 2.43 |
Profit Margin | 9.85% |
Operating Margin TTM | 12.99% |
Return On Assets TTM | 4.2% |
Return On Equity TTM | 6.42% |
Revenue TTM | 94.3M |
Revenue Per Share TTM | 3.85 |
Quarterly Revenue Growth YOY | -5.8999999999999995% |
Gross Profit TTM | 38.0M |
EBITDA | 11.9M |
Diluted Eps TTM | 0.37 |
Quarterly Earnings Growth YOY | -0.42 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Company Financials
| FY19 | Y/Y Change | |
|---|---|---|
Revenue | 79.6M | - |
Net Income | 15.4M | - |
Net Profit Margin | 19.38% | - |
| FY20 | Y/Y Change | |
|---|---|---|
Revenue | 89.1M | ↑ 11.85% |
Net Income | 19.0M | ↑ 23.42% |
Net Profit Margin | 21.38% | ↑ 2.0% |
| FY21 | Y/Y Change | |
|---|---|---|
Revenue | 104.0M | ↑ 16.82% |
Net Income | 20.0M | ↑ 4.97% |
Net Profit Margin | 19.22% | ↓ 2.16% |
| FY22 | Y/Y Change | |
|---|---|---|
Revenue | 103.3M | ↓ 0.66% |
Net Income | 6.2M | ↓ 68.77% |
Net Profit Margin | 6.04% | ↓ 13.18% |
| FY23 | Y/Y Change | |
|---|---|---|
Revenue | 97.1M | ↓ 6.05% |
Net Income | 11.6M | ↑ 86.22% |
Net Profit Margin | 11.97% | ↑ 5.93% |
| Q1 FY23 | Q/Q Change | |
|---|---|---|
Revenue | 48.5M | - |
Net Income | -311.9K | - |
Net Profit Margin | -0.64% | - |
| Q3 FY23 | Q/Q Change | |
|---|---|---|
Revenue | 24.5M | - |
Net Income | 2.3M | - |
Net Profit Margin | 9.33% | - |
| Q1 FY24 | Q/Q Change | |
|---|---|---|
Revenue | 22.7M | ↓ 7.29% |
Net Income | 2.4M | ↑ 3.36% |
Net Profit Margin | 10.4% | ↑ 1.07% |
| Q2 FY24 | Q/Q Change | |
|---|---|---|
Revenue | 22.7M | ↑ 0.0% |
Net Income | 2.4M | ↑ 0.0% |
Net Profit Margin | 10.4% | ↑ 0.0% |
| FY19 | Y/Y Change | |
|---|---|---|
Total Assets | 73.2M | - |
Total Liabilities | 13.5M | - |
| FY20 | Y/Y Change | |
|---|---|---|
Total Assets | 106.0M | ↑ 44.87% |
Total Liabilities | 21.3M | ↑ 57.33% |
| FY21 | Y/Y Change | |
|---|---|---|
Total Assets | 136.9M | ↑ 29.05% |
Total Liabilities | 30.0M | ↑ 40.98% |
| FY22 | Y/Y Change | |
|---|---|---|
Total Assets | 163.6M | ↑ 19.52% |
Total Liabilities | 24.9M | ↓ 17.14% |
| FY23 | Y/Y Change | |
|---|---|---|
Total Assets | 171.9M | ↑ 5.1% |
Total Liabilities | 25.1M | ↑ 0.72% |
| Q1 FY23 | Q/Q Change | |
|---|---|---|
Total Assets | 162.6M | ↓ 0.59% |
Total Liabilities | 23.2M | ↓ 6.73% |
| Q2 FY23 | Q/Q Change | |
|---|---|---|
Total Assets | 162.6M | ↑ 0.0% |
Total Liabilities | 23.2M | ↑ 0.0% |
| Q3 FY23 | Q/Q Change | |
|---|---|---|
Total Assets | 171.9M | ↑ 5.72% |
Total Liabilities | 25.1M | ↑ 7.99% |
| Q4 FY23 | Q/Q Change | |
|---|---|---|
Total Assets | 171.9M | ↑ 0.0% |
Total Liabilities | 25.1M | ↑ 0.0% |
| Q1 FY24 | Q/Q Change | |
|---|---|---|
Total Assets | 179.2M | ↑ 4.22% |
Total Liabilities | 29.6M | ↑ 18.0% |
| Q2 FY24 | Q/Q Change | |
|---|---|---|
Total Assets | 179.2M | ↑ 0.0% |
Total Liabilities | 29.6M | ↑ 0.0% |
| FY18 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | 11.8M | - |
Investing Cash Flow | -7.6M | - |
Financing Cash Flow | -4.2M | - |
| FY19 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | 9.3M | ↓ 21.23% |
Investing Cash Flow | -8.9M | ↑ 17.52% |
Financing Cash Flow | 923.8K | ↓ 122.01% |
| FY20 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | 5.3M | ↓ 42.78% |
Investing Cash Flow | -16.1M | ↑ 80.8% |
Financing Cash Flow | 1.7M | ↑ 84.76% |
| FY21 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | -54.7K | ↓ 101.03% |
Investing Cash Flow | -833.8K | ↓ 94.82% |
Financing Cash Flow | 1.9M | ↑ 8.99% |
| Q4 FY22 | Q/Q Change | |
|---|---|---|
Operating Cash Flow | -2.7M | ↑ 297.63% |
Investing Cash Flow | -1.9M | ↑ 0.0% |
Financing Cash Flow | 360.8K | ↓ 65.65% |
| Q1 FY23 | Q/Q Change | |
|---|---|---|
Operating Cash Flow | -682.1K | ↓ 74.85% |
Investing Cash Flow | -1.9M | ↑ 0.0% |
Financing Cash Flow | 1.1M | ↑ 191.08% |
| Q2 FY23 | Q/Q Change | |
|---|---|---|
Operating Cash Flow | -2.7M | ↑ 297.63% |
Investing Cash Flow | -1.9M | ↑ 0.0% |
Financing Cash Flow | 360.8K | ↓ 65.65% |
Technicals Summary
Sell
Neutral
Buy
Meihua International Medical Technologies Co Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Meihua International Medical Technologies Co Ltd | 1.94% | 65.06% | -43.55% | -91.87% | -91.87% |
 Intuitive Surgical, Inc. | 6.56% | 41.26% | 91.18% | 53.45% | 177.85% |
 Resmed Inc. | -2.51% | 33.07% | 63.68% | -8.76% | 83.88% |
 Becton, Dickinson And Company | 3.84% | 4.22% | -4.76% | -1.1% | -4.07% |
 Alcon Ag | -2.89% | 18.03% | 30.76% | 16.68% | 62.63% |
 Cooper Companies Inc., The | -1.41% | 20.24% | -66.42% | 5.22% | 50.71% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Meihua International Medical Technologies Co Ltd | 2.43 | 2.43 | NA | 0.0 | 0.06 | 0.04 | NA | 5.73 |
Intuitive Surgical, Inc. | 81.54 | 81.54 | 4.08 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 34.67 | 34.67 | 2.0 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 48.07 | 48.07 | 1.11 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
Alcon Ag | 42.58 | 42.58 | 3.58 | 3.06 | 0.05 | 0.03 | 0.0 | 42.35 |
Cooper Companies Inc., The | 59.32 | 59.32 | 11.0 | 3.66 | 0.05 | 0.03 | NA | 39.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Meihua International Medical Technologies Co Ltd | NA | $25.6M | -91.87% | 2.43 | 9.85% |
Intuitive Surgical, Inc. | Buy | $168.3B | 177.85% | 81.54 | 27.65% |
Resmed Inc. | Buy | $35.2B | 83.88% | 34.67 | 21.79% |
Becton, Dickinson And Company | Buy | $69.5B | -4.07% | 48.07 | 7.13% |
Alcon Ag | Buy | $46.6B | 62.63% | 42.58 | 11.44% |
Cooper Companies Inc., The | Buy | $21.3B | 50.71% | 59.32 | 9.45% |
Insights on Meihua International Medical Technologies Co Ltd
Decreasing Revenue
Revenue is down for the last 4 quarters, 48.51M → 22.67M (in $), with an average decrease of 19.0% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -311.91K → 2.35M (in $), with an average increase of 39.0% per quarter
Vs ISRG
In the last 1 year, Intuitive Surgical, Inc. has given 95.3% return, outperforming this stock by 139.4%
Institutional Holdings
Anson Funds Management LP
2.55%Renaissance Technologies Corp
0.10%UBS Group AG
0.09%Geode Capital Management, LLC
0.07%Morgan Stanley - Brokerage Accounts
0.01%
Company Information
Organization | Meihua International Medical Technologies Co Ltd |
Employees | 617 |
CEO | Mr. Wang Xin |
Industry | Miscellaneous |
Discover More
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$0.84
-20.0%
Invesco Bulletshares 2025 Hi
$0.84
-20.0%
Schwab International Dividend Equity Etf
$0.84
-20.0%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$0.84
-20.0%
Lightpath Technologies Inc
$0.84
-20.0%
Vaneck Vectors Global Alternative Energy Etf
$0.84
-20.0%
First Trust Flexible Municipal High Income Etf
$0.84
-20.0%
Drx Dly Reg Bank Bull 3x
$0.84
-20.0%
Graniteshares 2x Long Pltr Daily Etf
$0.84
-20.0%